Medix Biochemica is dedicated to providing you with the resources you need to accelerate the development of commercially ready products that impact patient care.
Independent, international and industry-leading
A truly global company with a proudly Finnish background, Medix Biochemica has offices and manufacturing facilities all around the world. Partnering with us means getting access to international, industry-leading expertise, meaning you can get to market quicker while maintaining quality.
All of our manufacturing sites stick to strict quality management systems and are ISO accredited. See our ISO certification below:
Enzyme Engineering: Directed Evolution and Rational Design for Enhanced DNA Polymerases and their Application (GQ 2023)
Double mutation near CDRs reduces antibody aggregation most effectively (PEGS Europe 2022)
A Highly Discriminating Taq polymerase Ideal for allele-specific PCR (AS-PCR) SNP detection and CRISPR Cas gene editing (AMP 2022)
Monoclonal Serum Amyloid A Antibodies Applicable to Human and Veterinary Diagnostic Immunoassays with Wide Detection Ranges (AACC 2021)
Novel Monoclonal Anti-Müllerian Hormone Antibodies Applicable to Sensitive Diagnostic Immunoassays (AACC 2019)
Calprotectin Antibodies With Different Binding Specificities Can Be Used as Tools to Detect Multiple Calprotectin Forms (AACC 2018)